Susan T.C.J.M. Arentsen-Peters

Author

Erasmus MC - Sophia Children’s Hospital ORCID

Also Known As

S T C J M Arentsen-Peters, S. T. C. J. M. Arentsen-Peters, S. T. J. C. M. Arentsen-Peters, Susan Arentsen-Peters, Susan Arentsen‐Peters, Susan T Arentsen-Peters, Susan T C J M Arentsen-Peters, Susan T. C. J. M. Arentsen-Peters, Susan T. C. J. M. Arentsen‐Peters, Susan T.C.J.M. Arentsen-Peters

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC - Sophia Children’s Hospital Hôpital Saint-Louis Charles University Stichting Kinderoncologie Nederland Erasmus MC

About

Susan T.C.J.M. Arentsen-Peters is an author at Erasmus MC - Sophia Children’s Hospital specializing in gene expression, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	150
2	Cell Biology	1	1	150
3	Molecular Genetics	1	1	150
4	Gene Expression	1	1	150
5	Genetics	1	1	150

Susan T.C.J.M. Arentsen-Peters

Publications

Citations

H-Index

Page 1

	Year	Citations
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Susan T.C.J.M. Arentsen-Peters, Blood	2011	327
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern Jasmijn de Rooij, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, Leukemia Hematological MalignancyGeneticsMolecular GeneticsGene ExpressionMedicine	2013	150
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Blood	2009	131
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia Brian V. Balgobind, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, Haematologica	2011	118
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia Brian V. Balgobind, M. M. Van den Heuvel-Eibrink, R. X. De Menezes, Haematologica	2010	116
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Susan T.C.J.M. Arentsen-Peters, Haematologica	2010	72
Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia Astrid A Danen-van Oorschot, Jenny E. Kuipers, Susan T.C.J.M. Arentsen-Peters, Pediatric Blood & Cancer	2011	47
Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in KMT2A-Rearranged Acute Lymphoblastic and Myeloid Leukemia Fabienne R. S. Adriaanse, Pauline Schneider, Susan T.C.J.M. Arentsen-Peters, International Journal of Molecular Sciences	2024	16
Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia Pauline Schneider, Nicholas T. Crump, Susan T.C.J.M. Arentsen-Peters, Experimental Hematology and Oncology	2023	14
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia Priscilla Wander, Susan T.C.J.M. Arentsen-Peters, Sandra S. Pinhanços, Translational Oncology	2021	13

Page 1